Covered recipient · General Payments record
ALVARO GENAO
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$1,502.88
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $559.26 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $241.64 | 8 |
| ABBVIE INC. | $152.34 | 8 |
| Janssen Scientific Affairs, LLC | $135.87 | 1 |
| Madrigal Pharmaceuticals | $29.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.34 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103786159 | CMS |
| ABBVIE INC. | $4.09 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103786161 | CMS |
| ABBVIE INC. | $33.68 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103786163 | CMS |
| ABBVIE INC. | $11.44 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103786165 | CMS |
| ABBVIE INC. | $5.86 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103786167 | CMS |
| ABBVIE INC. | $29.70 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103786169 | CMS |
| ABBVIE INC. | $8.71 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103786171 | CMS |
| ABBVIE INC. | $34.52 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103786173 | CMS |
| Gilead Sciences, Inc. | $1.65 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133773437 | CMS |
| Gilead Sciences, Inc. | $21.01 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133773439 | CMS |
| Gilead Sciences, Inc. | $27.89 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133773441 | CMS |
| Gilead Sciences, Inc. | $1.28 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133773443 | CMS |
| Gilead Sciences, Inc. | $19.75 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133773445 | CMS |
| Gilead Sciences, Inc. | $22.25 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133773447 | CMS |
| Gilead Sciences, Inc. | $122.43 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133773449 | CMS |
| Gilead Sciences, Inc. | $25.38 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133773451 | CMS |
| Janssen Scientific Affairs, LLC | $135.87 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078855612 | CMS |
| Madrigal Pharmaceuticals | $29.41 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144166598 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.